China Resources Sanjiu guarantees Tasly subsidiary's RMB 400m debt

China Resources Sanjiu Medical & Pharmaceutical (China Resources Sanjiu) announced that it has provided a guarantee for its controlling subsidiary, Tianjin Tasly Pharmaceutical Commercial Co., Ltd. (Pharmaceutical Commercial). The guarantee, signed on September 15, 2025, with China Minsheng Bank Tianjin Branch, provides a maximum debt limit of RMB 400 million for Pharmaceutical Commercial.

This guarantee is part of the 2025 annual guarantee plan for Tasly's wholly-owned subsidiaries, previously approved by China Resources Sanjiu's board of directors and shareholders. The total guaranteed amount for Pharmaceutical Commercial is RMB 400 million, and the cumulative actual guaranteed amount is also RMB 400 million, falling within the previously estimated quota. The guarantee is not secured by a counter-guarantee.

Pharmaceutical Commercial, the guaranteed entity, has a current asset-liability ratio of 70.22% as of June 30, 2025, and a net profit of RMB 9,058,505.13 for the first half of 2025. This move aims to meet the financing needs of Tasly’s businesses and improve financing efficiency, without external guarantees or overdue guarantee matters.